These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3335825)

  • 21. Influence of hormone replacement therapy (17 beta-OH estradiol and medroxyprogesterone acetate) on plasma concentration of prothrombin fragment F1+2 and thrombin-antithrombin III complex in postmenopausal woman.
    Ciepłluch R; Czestochowska E
    Acta Haematol Pol; 1996; 27(1):21-5. PubMed ID: 8629439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA; Mink IB
    Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J; Hammar M
    Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Eilertsen AL; Sandvik L; Mowinckel MC; Andersen TO; Qvigstad E; Sandset PM
    Thromb Res; 2007; 120(3):371-9. PubMed ID: 17156824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
    Shirk RA; Zhang Z; Winneker RC
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):361-8. PubMed ID: 15857755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study.
    Sidelmann JJ; Jespersen J; Andersen LF; Skouby SO;
    BJOG; 2003 Jun; 110(6):541-7. PubMed ID: 12798469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombosis and hormone replacement therapy in postmenopausal women.
    Saleh AA; Dorey LG; Dombrowski MP; Ginsburg KA; Hirokawa S; Kowalczyk C; Hirata J; Bottoms S; Cotton DB; Mammen EF
    Am J Obstet Gynecol; 1993 Dec; 169(6):1554-7. PubMed ID: 8267061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in coagulation factors in postmenopausal women on ethinyl oestradiol.
    Hunter DJ; Anderson AB; Haddon M
    Br J Obstet Gynaecol; 1979 Jun; 86(6):488-90. PubMed ID: 465400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate].
    Hayashi T; Takenawa J; Ryoji O; Hiura M; Taki Y; Kiriyama T
    Hinyokika Kiyo; 1989 May; 35(5):807-13. PubMed ID: 2478002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hormone replacement on hemostasis in spontaneous menopause.
    Demirol A; Baykal C; Kirazli S; Ayhan A
    Menopause; 2001; 8(2):135-40. PubMed ID: 11256874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian pattern of prolactin secretion in postmenopausal women receiving estrogen with or without progestin.
    Chang RJ; Davidson BJ; Carlson HE; Judd HL
    Am J Obstet Gynecol; 1982 Oct; 144(4):402-7. PubMed ID: 7124858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in plasma renin concentration, activity and substrate after twentyeight days' treatment with micronized estrogen, ethinylestradiol and norethisterone-acetate in postmenopausal women.
    Brøns M; Jacobsen JG; Kristoffersen K
    Acta Med Scand Suppl; 1981; 646():94-7. PubMed ID: 7018189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.